- Email: [email protected]
Obtaining Accurate Thromboembolism Rates Post-Endovenous Laser Ablation and Sclerotherapy Procedures for Treatment of Chronic Venous Insufficiency
October 2013, Vol 144, No. 4_MeetingAbstracts Education, Teaching, and Quality Improvement | October 2013
Obtaining Accurate Thromboembolism Rates Post-Endovenous Laser Ablation and Sclerotherapy Procedures for Treatment of Chronic Venous Insufficiency Chris McGreevey, MS; Christopher Bulger, MD Vein Clinics of America, Downers Grove, IL Chest. 2013;144(4_MeetingAbstracts):575A. doi:10.1378/chest.1704896
Abstract SESSION TITLE:Patient Safety Posters SESSION TYPE: Original Investigation Poster PRESENTED ON: Wednesday, October 30, 2013 at 01:30 PM - 02:30 PM PURPOSE: Review and analyze the incidence of Deep Venous Thrombosis (DVT), Pulmonary embolism (PE), and Supe rficial Venous Thrombosis (SVT) after endovenous laser ablation (ELA), ultrasound -guided foam sclerotherapy (UGS), and visually- guided liquid sclerotherapy (VGS)in order to provide better informed consent to patients. Our clinical observations demonstrate the post -treatment thrombus incidents occur within 1 and 30 days of thermal or chemical ablation procedures using a large population of patients across 46 physicians’ office-based surgery practices in 14 states. METHODS: This study is a retrospective obser vation review of thrombotic complication rates in a single specialty group practice, over the course of two years 2010 -2011 after implementing ICAVL-based Ultrasound protocols to examine the Deep Venous System of the lower extremities. 189,221 total proced ures were performed during this time. Incidence of the specific thrombotic complication rates are expressed both in terms of total procedures performed and related to the specific procedures. Endovenous heat induced thrombus (EHIT Class 1, 2, 3, 4) events post -ELA were stratified, and noted both independently and combined (e.g., EHIT 2, 3, 4 combined with DVT events; EHIT 1 combined with SVT events).
RESULTS: The venous thromboembolism rate for ELA is 0.5% overall with a 0.2% DVT, 0.2% SVT and 0.05% PE rate s. Sclerotherapy complication rates are 0.05% DVT, 0.1% SVT, and 0.01% PE. Specific visually -guided sclerotherapy to treat the patient’s surface veins demonstrate venous thromboembolism (VTE) rates of 0.03%. CONCLUSIONS: The thrombotic incident rates, afte r endovenous ablative procedures for treatment of CVI, are less than certain previously reported sources. CLINICALIMPLICATIONS:Though these complications can carry significant morbidity associated with them, these procedures remain safe, and continued informed consent relies on sharing up -to-date information with the patient. DISCLOSURE: The following authors have nothing to disclose: Chris McGreevey, Christopher Bulger No Product/Research
Disclosure Information
Obtaining Accurate Thromboembolism Rates Post-Endovenous Laser Ablation and Sclerotherapy Procedures for Treatment of Chronic Venous Insufficiency Chris McGreevey, MS; Christopher Bulger, MD Vein Clinics of America, Downers Grove, IL Chest. 2013;144(4_MeetingAbstracts):575A. doi:10.1378/chest.1704896
Abstract SESSION TITLE:Patient Safety Posters SESSION TYPE: Original Investigation Poster PRESENTED ON: Wednesday, October 30, 2013 at 01:30 PM - 02:30 PM PURPOSE: Review and analyze the incidence of Deep Venous Thrombosis (DVT), Pulmonary embolism (PE), and Supe rficial Venous Thrombosis (SVT) after endovenous laser ablation (ELA), ultrasound -guided foam sclerotherapy (UGS), and visually- guided liquid sclerotherapy (VGS)in order to provide better informed consent to patients. Our clinical observations demonstrate the post -treatment thrombus incidents occur within 1 and 30 days of thermal or chemical ablation procedures using a large population of patients across 46 physicians’ office-based surgery practices in 14 states. METHODS: This study is a retrospective obser vation review of thrombotic complication rates in a single specialty group practice, over the course of two years 2010 -2011 after implementing ICAVL-based Ultrasound protocols to examine the Deep Venous System of the lower extremities. 189,221 total proced ures were performed during this time. Incidence of the specific thrombotic complication rates are expressed both in terms of total procedures performed and related to the specific procedures. Endovenous heat induced thrombus (EHIT Class 1, 2, 3, 4) events post -ELA were stratified, and noted both independently and combined (e.g., EHIT 2, 3, 4 combined with DVT events; EHIT 1 combined with SVT events).
RESULTS: The venous thromboembolism rate for ELA is 0.5% overall with a 0.2% DVT, 0.2% SVT and 0.05% PE rate s. Sclerotherapy complication rates are 0.05% DVT, 0.1% SVT, and 0.01% PE. Specific visually -guided sclerotherapy to treat the patient’s surface veins demonstrate venous thromboembolism (VTE) rates of 0.03%. CONCLUSIONS: The thrombotic incident rates, afte r endovenous ablative procedures for treatment of CVI, are less than certain previously reported sources. CLINICALIMPLICATIONS:Though these complications can carry significant morbidity associated with them, these procedures remain safe, and continued informed consent relies on sharing up -to-date information with the patient. DISCLOSURE: The following authors have nothing to disclose: Chris McGreevey, Christopher Bulger No Product/Research
Disclosure Information